Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Experimental Hematology & Oncology|August 6, 2024
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patientsEmilia Gigliotta, Federica Plano, Giusy Corsale, et al.
Hematology Reports|January 17, 2023
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back AgainFederica Plano, Anna Maria Corsale, Emilia Gigliotta, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2015
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysisMariamena Arbitrio, Maria Teresa Di Martino, Vito Barbieri, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 28, 2026
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life ApplicationRoberto Mina, Elisabetta Antonioli, Gregorio Barilà, et al.
Journal of Cellular Physiology|December 21, 2012
miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone diseaseMarco Rossi, Maria Rita Pitari, Nicola Amodio, et al.
Oncotarget|May 29, 2018
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cellsSabrina D'Agostino, Delia Lanzillotta, Mariaconcetta Varano, et al.
Cancer Biology & Therapy|June 14, 2013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patientsCirino Botta, Vito Barbieri, Domenico Ciliberto, et al.
Biomarker Research|February 10, 2025
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemiaAnnalisa Chiarenza, Gaia Vertillo Aluisio, Nunziatina Laura Parrinello, et al.
Journal of Ovarian Research|May 23, 2016
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patientsChiara Mignogna, Nicoletta Staropoli, Cirino Botta, et al.
Cancer Biology & Therapy|April 29, 2011
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patientsPierpaolo Correale, Cirino Botta, Assunta Basile, et al.
Pageof 10